Sigma-Aldrich, HSI sign distribution agreement for patented stable isotope labeled synthetic reagents

NewsGuard 100/100 Score

Sigma-Aldrich® (Nasdaq: SIAL) announced today that it has signed an agreement with New Mexico Highlands University through its licensee, Highlands Stable Isotope Corp. (HSI), to exclusively distribute a novel set of patented stable isotope labeled synthetic reagents (www.sigma-aldrich.com/sinext).  Under the terms of the agreement, HSI, a leader in the synthesis of amino acids, natural products, monomers for the materials science industry and heterocyclic chemistry, will initially offer approximately 16 compounds in all isotopic combinations through Sigma-Aldrich. In total, HSI's portfolio currently includes more than 75 newly patented isotopically labeled synthons for the research community, and after the initial offering Sigma-Aldrich expects to distribute all of these materials through its ISOTEC® Stable Isotopes product line.

"Sigma-Aldrich is a leader in manufacturing and providing stable isotope products including synthetic building blocks. A partnership with HSI will enable Sigma-Aldrich to provide several new classes of stable isotope reagents," said Dr. C.T. Tan, ISOTEC Stable Isotope's R&D Manager at Sigma-Aldrich.  "We believe these reagents will improve the speed and quality of the synthesis of stable isotope compounds. The application of these new reagents will help us speed up the drug discovery process, especially for heavyweight deuterated drug discovery."

Diane Szydel, general manager of ISOTEC Stable Isotopes at Sigma-Aldrich, added, "We are excited about our agreement with HSI.  By being the exclusive provider of these patented and novel compounds, we not only expand our comprehensive stable isotope product offering, but believe we will also be able to better serve our customers' research needs."

Dr. Rodolfo Martinez, lead scientist for HSI and principal author of this next generation of patented, labeled synthons, said: "We are pleased to collaborate with Sigma-Aldrich.  Researchers can be assured that the quality to which they are accustomed will also be represented in all HSI products."

Source:

Sigma-Aldrich

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings